tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Buy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
PremiumRatingsBuy Rating for Radiopharm Theranostics Limited Driven by Promising Clinical Developments and Growth Potential
1M ago
Biotech Alert: Searches spiking for these stocks today
Premium
The Fly
Biotech Alert: Searches spiking for these stocks today
1M ago
Radiopharm price target raised to $16 from $13 at B. Riley
Premium
The Fly
Radiopharm price target raised to $16 from $13 at B. Riley
1M ago
Radiopharm price target lowered to $13 from $15 at B. Riley
PremiumThe FlyRadiopharm price target lowered to $13 from $15 at B. Riley
2M ago
Radiopharm receives approval to initiate Phase 1 trial of RAD 402
Premium
The Fly
Radiopharm receives approval to initiate Phase 1 trial of RAD 402
2M ago
Radiopharm announces 50% enrollment in Phase 2b trial of RAD101
Premium
The Fly
Radiopharm announces 50% enrollment in Phase 2b trial of RAD101
2M ago
Radiopharm provides update on pipeline of clinical programs
PremiumThe FlyRadiopharm provides update on pipeline of clinical programs
3M ago
Radiopharm launches A$5M share purchase plan
Premium
The Fly
Radiopharm launches A$5M share purchase plan
3M ago
Radiopharm Theranostics trading halted, volatility trading pause
Premium
The Fly
Radiopharm Theranostics trading halted, volatility trading pause
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100